Last month I wrote a post about intestinal blockage and how serious a disorder it is - especially because it is high season for this disorder during the holidays. However, now entering January and relentless slimming season, this may also turn out to be high season for intestinal blockage due to the increase in prescriptions of certain popular weightloss medications.
Thinking of kick-starting January's weight loss with medical help?
Ozempic and Wegovy - both drugs where side effects include reducing intestinal peristalsis to such an extent that the FDA issued a letter in the autumn in which they made it clear that they will henceforth warn against acute intestinal blockage on the packaging. The risk of intestinal blockage is something most of us incl. health professionals and doctors have been unaware of with this apparent weight loss miracle drug.
Intestinal blockage is potentially life-threatening and if you already have a history of digestive disorders, you should stay far away from these medicines. Regardless of the fact that obesity is linked to a domino effect of biochemical problems in the body, the risk of intestinal blockage is simply too serious.
Last year, I admittedly also considered whether this remedy could be included as part of a broad-spectrum aid to kick-start weight loss in clients with a particularly addictive relationship with food - both to break the habit but also to change the brain's reward system. Unfortunately, it has become more apparent that the problems with muscle loss (leading to reduced metabolism - and increased tendency to gain more weight after treatment) as well as the side effects around digestion - and especially the risk of intestinal blockage - are not sustainable nor worth it.